Simcere Pharmaceutical Group (NYSE:SCR) Stock Quotes and News

Simcere Pharmaceutical Group (SCR) 0.00 -0.01

Price Open:	9.26	Day's Range:	0.00000 - 9.59000
Price Close:	9.27	52wk Range:	0.00000 - 10.36
Price Day Change:	-0.01	Volume:	5,450
Price % Change:	-0.11	Market Cap:	486.9M
Bid:	9.01000	PE Ratio:	53.28
Ask:	0.00000	EPS Diluted:	0.174

Trade SCR NOW!

The Latest On SCR

Simcere Pharmaceutical Group Special Committee Retains UBS as Financial Advisor to Assist in Considering Going Private Offer 4/3/13 6:06am

A Peek Into The Market Before The Trading Starts 3/22/13 7:20am

Simcere Pharmaceutical Group Receives Approval for GMP Certification of Flu Vaccine Production Facility in China 3/22/13 6:48am

Benzinga's M&A Chatter for Monday Monday March 11, 2013 3/11/13 5:21pm

Market Wrap for Monday, March 11: Stocks Continue to Rise to Kick Off Week 3/11/13 4:19pm

Simcere Pharmaceutical Group Receives $9.56/ADS Going Private Proposal 3/11/13 8:10am

Simcere Pharmaceutical Sells Equity Interest in Shanghai Celgen 1/22/13 6:47am

Apexigen Announces Simcere Pharmaceutical Group Receives Approval in China for Cancer Trials 11/12/12 7:21am

Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer 9/13/12 7:01am

Simcere Pharma Names Liu CEO 9/13/12 6:37am

US Stock Futures Down After China Trade Data 8/10/12 6:35am

Earnings Scheduled For August 10, 2012 8/10/12 3:18am

Press Releases

Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2013 Results 5/9/13 Newswire

Simcere Pharmaceutical Group Filed 2012 Annual Report on Form 20-F 4/27/13 Newswire

Simcere Pharmaceutical Group to Announce First Quarter 2013 Financial Results on Thursday, May 9, 2013 4/26/13 Newswire

Simcere Pharmaceutical Group Announces its Special Committee's Engagement of Financial Advisor 4/3/13 Newswire

Simcere Pharmaceutical Group Announces Issuance of GMP Certificate to Simcere Vaxtec 3/22/13 Newswire

Simcere Pharmaceutical Group Announces its Special Committee's Engagement of Legal Counsel 3/12/13 Newswire

Quarterly Changes to the NASDAQ Golden Dragon China Index 3/11/13 GlobeNewswire

Simcere Pharmaceutical Group Announces Receipt of "Going Private" Proposal 3/11/13 Newswire

Simcere Pharmaceutical Group Reports Preliminary Unaudited Fourth Quarter And Full Year 2012 Results 3/7/13 Newswire

Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2012 Financial Results on Thursday, March 7, 2013 2/25/13 Newswire

Simcere Pharmaceutical Group Announces Sale of Equity Interest in Shanghai Celgen 1/22/13 Newswire

Get the latest SCR stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Simcere Pharmaceutical Group stock price.

Partner Headlines

Simcere Beats 1Q Earnings & Revenue Estimate - Analyst Blog 5/10/13

Good News for Simcere Pharma - Analyst Blog 3/28/13

Simcere Gets Buyout Proposal - Analyst Blog 3/13/13

Simcere Misses Estimates in 4Q - Analyst Blog 3/8/13

Simcere 3Q Earnings Matches - Analyst Blog 11/19/12

Simcere Misses 2Q Estimates - Analyst Blog 8/13/12

BMY Inks Deal with Chinese University - Analyst Blog 5/15/12

A Chinese Small Cap for Diogenes (SCR, WMT, AAPL) 5/1/12

Revenues Decline at Simcere Pharma - Analyst Blog 3/9/12

Bristol-Myers, Simcere Extend Ties - Analyst Blog 12/14/11

Simcere Pharma Misses on All Fronts - Analyst Blog 11/15/11